180 related articles for article (PubMed ID: 17322930)
1. Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation.
Sanz MA; Labopin M; Gorin NC; de la Rubia J; Arcese W; Meloni G; Bacigalupo A; Alessandrino P; Carreras E; Iriondo A; Novitzky N; Jacobs P; Bandini G; Lo-Coco F; Frassoni F; Rocha V;
Bone Marrow Transplant; 2007 Apr; 39(8):461-9. PubMed ID: 17322930
[TBL] [Abstract][Full Text] [Related]
2. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E
Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
[TBL] [Abstract][Full Text] [Related]
3. European survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Working Party on Acute Leukemia of the European Cooperative Group for Bone Marrow Transplantation (EMBT).
Mandelli F; Labopin M; Granena A; Iriondo A; Prentice G; Bacigalupo A; Sierra J; Meloni G; Frassoni F; Goldman J
Bone Marrow Transplant; 1994 Aug; 14(2):293-8. PubMed ID: 7994245
[TBL] [Abstract][Full Text] [Related]
4. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
Gorin NC; Labopin M; Frassoni F; Milpied N; Attal M; Blaise D; Meloni G; Iori AP; Michallet M; Willemze R; Deconninck E; Harousseau JL; Polge E; Rocha V
J Clin Oncol; 2008 Jul; 26(19):3183-8. PubMed ID: 18506024
[TBL] [Abstract][Full Text] [Related]
5. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
de Botton S; Fawaz A; Chevret S; Dombret H; Thomas X; Sanz M; Guerci A; San Miguel J; de la Serna J; Stoppa AM; Reman O; Stamatoulas A; Fey M; Cahn JY; Sotto JJ; Bourhis JH; Parry A; Chomienne C; Degos L; Fenaux P
J Clin Oncol; 2005 Jan; 23(1):120-6. PubMed ID: 15534358
[TBL] [Abstract][Full Text] [Related]
6. The role of bone marrow transplantation in acute promyelocytic leukemia.
Nabhan C; Mehta J; Tallman MS
Bone Marrow Transplant; 2001 Aug; 28(3):219-26. PubMed ID: 11535988
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
[TBL] [Abstract][Full Text] [Related]
8. Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation.
Gorin NC; Labopin M; Boiron JM; Theorin N; Littlewood T; Slavin S; Greinix H; Cahn JY; Alessandrino EP; Rambaldi A; Nagler A; Polge E; Rocha V;
J Clin Oncol; 2006 Aug; 24(24):3959-66. PubMed ID: 16880451
[TBL] [Abstract][Full Text] [Related]
9. Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remission.
Gorin NC; Labopin M; Blaise D; Reiffers J; Meloni G; Michallet M; de Witte T; Attal M; Rio B; Witz F; Fouillard L; Willemze R; Rocha V;
J Clin Oncol; 2009 Aug; 27(24):3987-93. PubMed ID: 19597030
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Labopin M; Frassoni F; Sanz G; Demeocq F; Prentice H; Cahn JY; Barbui T; Meloni G; Schaefer U; Reiffers J; Gorin N
Bone Marrow Transplant; 1999 Aug; 24(4):389-96. PubMed ID: 10467328
[TBL] [Abstract][Full Text] [Related]
11. Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research.
Lazarus HM; Pérez WS; Klein JP; Kollman C; Bate-Boyle B; Bredeson CN; Gale RP; Geller RB; Keating A; Litzow MR; Marks DI; Miller CB; Douglas Rizzo J; Spitzer TR; Weisdorf DJ; Zhang MJ; Horowitz MM
Br J Haematol; 2006 Mar; 132(6):755-69. PubMed ID: 16487177
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
13. Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years.
Giebel S; Labopin M; Holowiecki J; Labar B; Komarnicki M; Koza V; Masszi T; Mistrik M; Lange A; Hellmann A; Vitek A; Pretnar J; Mayer J; Rzepecki P; Indrak K; Wiktor-Jedrzejczak W; Wojnar J; Krawczyk-Kulis M; Kyrcz-Krzemien S; Rocha V
Ann Hematol; 2009 Oct; 88(10):1005-13. PubMed ID: 19301005
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the outcomes of children with acute myelogenous leukemia in either first or second complete remission (CR1 vs CR2) following allogeneic hematopoietic stem cell transplantation at a single transplant center.
Gassas A; Ishaqi MK; Afzal S; Finkelstein-Shechter T; Dupuis A; Doyle J
Bone Marrow Transplant; 2008 Jun; 41(11):941-5. PubMed ID: 18264141
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
17. [Hematopoietic stem cell transplantation in the second or later complete remission in acute promyelocytic leukemia initially treated with all-trans retinoic acid].
Fujita H; Nakaya A; Kato J; Tachibana T; Takemura S; Hyo R; Kawano T; Tanaka M; Taguchi J; Maruta A; Fujimaki K; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Oct; 46(10):1095-9. PubMed ID: 16440769
[TBL] [Abstract][Full Text] [Related]
18. A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Al-Ali HK; Brand R; van Biezen A; Finke J; Boogaerts M; Fauser AA; Egeler M; Cahn JY; Arnold R; Biersack H; Niederwieser D; de Witte T
Leukemia; 2007 Sep; 21(9):1945-51. PubMed ID: 17611571
[TBL] [Abstract][Full Text] [Related]
19. Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis.
Reiffers J; Labopin M; Sanz M; Korbling M; Blaise D; De La Rubia J; Gorin NC
Bone Marrow Transplant; 2000 Jun; 25(11):1115-9. PubMed ID: 10849522
[TBL] [Abstract][Full Text] [Related]
20. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
